SandersMS, McCormickEJ. Human Factors in Engineering and Design, 7th ed. New York: McGraw-Hill, 1993.
2.
Draft Guidance for Industry and Food and Drug Administration Staff—Applying Human Factors and Usability Engineering to Optimize Medical Device Design [article online], 2011. Available at www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm259748.htm
3.
Baxter Colleague Single and Triple Channel Volumetric Infusion Pumps—Recall, Refund and Replacement [article online], 2010. Available at www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm235273.htm
4.
SchaefferNE. The role of human factors in the design and development of an insulin pump. J Diabetes Sci Technol, 2012; 6: 260–64.
5.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther, 2010; 12: 679–84.
6.
PeyrotM, RubinRR. Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial. Diabet Med, 2013; 30: 464–67.
7.
ChaseHP, BeckRW, XingD, TamborlaneWV, CoffeyJ, FoxLA, IvesB, KeadyJ, KollmanC, LaffelL, RuedyKJ. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther, 2010; 12: 507–15.
8.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, TamborlaneWV, BeckRW, BodeBW, BuckinghamB, ChaseHP, ClemonsR, Fiallo-ScharerR, FoxLA, GilliamLK, HirschIB, HuangES, KollmanC, KowalskiAJ, LaffelL, LawrenceJM, LeeJ, MaurasN, O'GradyM, RuedyKJ, TanseyM, TsalikianE, WeinzimerS, WilsonDM, WolpertH, WysockiT, XingD. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med, 2008; 359: 1464–76.
9.
GaudieriPA, ChenR, GreerTF, HolmesCS. Cognitive function in children with type 1 diabetes: a meta-analysis. Diabetes Care, 2008; 31: 1892–97.
10.
PickupJC, SuttonAJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med, 2008; 25: 765–74.
11.
LyTT, NicholasJA, RetterathA, LimEM, DavisEA, JonesTW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA, 2013; 310: 1240–47.
12.
ChoudharyP, RamasamyS, GreenL, GallenG, PenderS, BrackenridgeA, AmielSA, PickupJC. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care, 2013; 36: 4160–62.
13.
CoxD, ClarkeW, RitterbandL, Gonder-FrederickL, MageeJ. Blood glucose awareness training delivered over the Internet. Diabetes Care, 2008; 31: 1527–28.
14.
WoodJR, MorelandEC, VolkeningLK, SvorenBM, ButlerDA, LaffelLM. Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care, 2006; 29: 2355–60.
15.
RenardE, GuerciB, LeguerrierAM, BoizelR; Accu-Chek FlexLink Study Group. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study. Diabetes Technol Ther, 2010; 12: 769–73.
16.
PrenskyM. Digital Natives, digital Immigrants, Part 1. In: On the Horizon. Lincoln: NCB University Press, 2001.
17.
WysockiT, GavinL. Paternal involvement in the management of pediatric chronic diseases: associations with adherence, quality of life, and health status. J Pediatr Psychol, 2006; 31: 501–11.
18.
KingPS, BergCA, ButnerJ, ButlerJM, WiebeDJ. Longitudinal trajectories of parental involvement in Type 1 diabetes and adolescents' adherence. Health Psychol, 2014; 33: 424–32.
19.
TriefPM, SandbergJ, GreenbergRP, GraffK, CastronovaN, YoonM, WeinstockRS. Describing support: a qualitative study of couples living with diabetes. Fam Syst Health, 2003; 21: 57–67.
20.
ShalitinS, GilM, NimriR, de VriesL, GavanMY, PhillipM. Predictors of glycaemic control in patients with type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med, 2010; 27: 339–47.
21.
ThrailkillKM, MoreauCS, SwearingenC, RettigantiM, EdwardsK, MoralesAE, KempSF, FrindikJP, FowlkesJL. Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic b-cell function in type 1 diabetes. Diabetes Technol Ther, 2011; 13: 1023–30.
22.
PihokerC, BadaruA, AndersonA, MorganT, DolanL, DabeleaD, ImperatoreG, LinderB, MarcovinaS, Mayer-DavisE, ReynoldsK, KlingensmithGJ, ARCH for Diabetes in Youth Study Group. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the SEARCH for diabetes in youth study. Diabetes Care, 2013; 36: 27–33.
